Protective effects of α-tocopherol and tiopronin against cisplatin-induced ototoxicity

References

• Kim ES, Glisson BS. Treatment of metastatic head and neck cancer: chemotherapy and novel agents. Cancer Treat Res 2003; 114: 295–314.
   PubMedGoogle Scholar
• Harries M, Gore M. Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosis. Lancet Oncol 2002; 3: 529–36.
   PubMedGoogle Scholar
• Valentini V, Coco C, Cellini N, Picciocchi A, Fares MC, Rosetto ME, et al. Ten years of preoperative chemor-adiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 2001; 51: 371–83.
   PubMed Web of Science ®Google Scholar
• Estrem SA, Babin RW, Ryu JH, Moore KC. Cis-diamminedichloroplatinum (II) ototoxicity in the guinea pig. Otolaryngol Head Neck Surg 1981; 89: 638–45.
   PubMed Web of Science ®Google Scholar
• Lauren G, Bagger-Sjoback D. Dose-dependent inner ear changes after i.v. administration of cisplatin. J Otolar-yngol 1991; 20: 158–67.
   Google Scholar
• Tange RA, Vuzevski VD. Changes of the stria vascularis of the guinea pig due to cis-platinum. Arch Otorhino-laryngol 1984; 239: 41–7.
   PubMed Web of Science ®Google Scholar
• Cardinaal RM, de Groot JC, Huizing EH, Veldman JE, Smoorenburg GF. Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea. Hear Res 2000; 144: 135–46.
   PubMed Web of Science ®Google Scholar
• Zheng JL, Gao WQ. Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures. Eur J Neurosci 1996; 8: 1897–905.
   PubMed Web of Science ®Google Scholar
• Gabaizadeh R, Staecker H, Liu W, Kopke R, Malgrange B, Lefebvre PP, et al. Protection of both auditory hair cells and auditory neurons from cisplatin induced damage. Acta Otolaryngol (Stockh) 1997; 117: 232–8.
   PubMed Web of Science ®Google Scholar
• Appenroth D, Winnefeld K. Role of glutathione for cisplatin nephrotoxicity in young and adult rats. Ren Fail 1993; 15: 135–9.
   PubMed Web of Science ®Google Scholar
• Ravi R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 1995; 76: 386–94.
   Google Scholar
• Clerici WJ, Hensley K, DiMartino DL, Butterfield DA. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res 1996; 98: 116–24.
   PubMed Web of Science ®Google Scholar
• Liu W, Staecker H, Stupak H, Malgrange B, Lefebvre P, Van De Water TR. Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells. Neuroreport 1998; 3: 2609–14.
   Google Scholar
• Alam SA, Ikeda K, Oshima T, Suzuki M, Kawase T, Kikuchi T, et al. Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea. Hear Res 2000; 141: 28–38.
   PubMed Web of Science ®Google Scholar
• Huang T, Cheng AG, Stupak H, Liu W, Kim A, Staecker H, et al. Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies. Int J Dev Neurosci 2000; 18: 259–70.
   PubMed Web of Science ®Google Scholar
• Teranishi M, Nakashima T, Wakabayashi T. Effects of alpha-tocopherol on cisplatin-induced ototoxicity in guinea pigs. Hear Res 2001; 51: 61–70.
   Google Scholar
• Bertolaso L, Martini A, Bindini D, Lanzoni I, Parmeg-giani A, Vitali C, et al. Apoptosis in the 0C-k3 immortalized cell line treated with different agents. Audiology 2001; 40: 327–35.
   Google Scholar
• Wang J, Lloyd Faulconbridge RV, Fetoni AR, Guitton MJ, Pujol R, Puel JL. Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig. Neuropharmacology 2003; 45: 380–93.
   PubMed Web of Science ®Google Scholar
• Devarajan P, Savoca M, Castaneda MP, Park MS, Esteban-Cruciani N, Kalinec G, et al. Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways. Hear Res 2002; 174: 45–54.
   Google Scholar
• Sergi B, Ferraresi A, Troiani D, Paludetti G, Fetoni AR. Cisplatin otovestibular toxicity in experimental model. Hear Res 2003; 182: 56–64.
   Google Scholar
• Appenroth D, Frob S, Kersten L, Splinter FK, Winne-feld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol 1997; 71: 677–83.
   Google Scholar
• Zhang JG, Viale M, Esposito M, Lindup WE. Tiopro-nin protects against the nephrotoxicity of cisplatin in the rat. Hum Exp Toxicol 1999; 18: 713–7.
   PubMed Web of Science ®Google Scholar
• Osakada F, Hashino A, Kume T, Katsuki H, Kaneko S, Akaike A. Neuroprotective effects of alpha-tocopherol on oxidative stress in rat striatal cultures. Eur J Pharmacol 2003; 465: 15–22.
   PubMedGoogle Scholar
• Hou F, Wang S, Zhai S, Hu Y, Yang W, He L. Effect of a-tocopherol on noise-induced hearing loss in guinea pigs. Hear Res 2003; 179: 1–8.
   PubMed Web of Science ®Google Scholar
• Fetoni AR, Sergi B, Scarano E, Paludetti G, Ferraresi A, Troiani D. Protective effects of alpha-tocopherol against gentamicin-induced oto-vestibulo toxicity: an experimental study. Acta Otolaryngol 2003; 123: 192–7.
   PubMed Web of Science ®Google Scholar
• Viale M, Zhang JG, Pastrone I, Mariggio MA, Esposito M, Lindup E. Cisplatin combined with tiopronin or sodium thiosulfate: cytotoxicity in vitro and antitumor activity in vivo. Anticancer Drugs 1999; 10: 419–28.
   PubMed Web of Science ®Google Scholar
• Labadarios D, Davis M, Portmann B, Williams R. Paracetamol-induced hepatic necrosis in the mouse-relationship between covalent binding, hepatic glu-tathione depletion and the protective effect of alpha-mercaptopropionylglycine. Biochem Pharmacol 1977; 26: 31–5.
   PubMed Web of Science ®Google Scholar
• Berio A, Piazzi A. Prophylaxis of cystine calculi by low dose of alpha-mercapto-propionyl-glycine administered every other day. Panminerva Med 1998; 40: 244–6.
   PubMedGoogle Scholar
• Pryor WA. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000; 28: 141–64.
   PubMed Web of Science ®Google Scholar
• Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, et al. A controlled trial of selegiline, alpha tocopherol or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative study. N Engl J Med 1997; 336: 1216–22.
   Google Scholar
• Hogue A, Albanes D, Lippman SM, Spitz MR, Taylor PR, Klein EA, et al. Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control 2001; 12: 627–33.
   PubMed Web of Science ®Google Scholar